• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期癌症患者使用完全植入式静脉输液港系统的并发症风险更高——单中心回顾性分析。

Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.

机构信息

Department of Haematology and Oncology, Mackay Memorial Hospital, Taipei, Taiwan.

出版信息

Palliat Med. 2013 Feb;27(2):185-91. doi: 10.1177/0269216311428777. Epub 2011 Nov 29.

DOI:10.1177/0269216311428777
PMID:22126844
Abstract

BACKGROUND

Totally implantable port systems are generally recommended for prolonged central venous access in diverse settings, but their risk of complications remains unclear for patients with advanced cancer.

AIM

The aim of this study was to assess the risk of port system failure in patients with advanced cancer.

DESIGN

We conducted a retrospective cohort study in a comprehensive cancer centre.

SETTING/PARTICIPANTS: A detailed chart review was conducted among 566 patients with 573 ports inserted during January-June, 2009 (average 345.3 catheter-days). Cox regression analysis was applied to evaluate factors during insertion and early maintenance that could lead to premature removal of the port systems due to infection or occlusion.

RESULTS

Port system-related infection was significantly associated with receiving palliative care immediately after implantation (hazard ratio, HR = 7.3, 95% confidence interval, 95% CI = 1.2-46.0), after adjusting for probable confounders. Primary cancer site also impacted the occurrence of device-related infection. Receiving oncologic/palliative care (HR = 3.0, P = 0.064), advanced cancer stage (HR = 6.5, P = 0.077) and body surface area above 1.71 m(2) (HR = 3.4, P = 0.029) increased the risk of port system occlusion.

CONCLUSIONS

Our study indicates that totally implantable port systems yield a higher risk of complications in terminally ill patients. Further investigation should be carefully conducted to compare outcomes of various central venous access devices in patients with advanced cancer and to develop preventive strategies against catheter failure.

摘要

背景

在各种情况下,完全植入式端口系统通常被推荐用于延长中心静脉通路,但它们在晚期癌症患者中的并发症风险尚不清楚。

目的

本研究旨在评估晚期癌症患者中端口系统故障的风险。

设计

我们在一家综合性癌症中心进行了一项回顾性队列研究。

设置/参与者:在 2009 年 1 月至 6 月期间,对 566 名患者的 573 个端口进行了详细的图表审查(平均导管天数为 345.3 天)。应用 Cox 回归分析评估了插入和早期维护期间可能导致端口系统因感染或阻塞而提前移除的因素。

结果

端口系统相关感染与植入后立即接受姑息治疗显著相关(危险比,HR = 7.3,95%置信区间,95%CI = 1.2-46.0),在调整了可能的混杂因素后。原发癌部位也影响了器械相关感染的发生。接受肿瘤/姑息治疗(HR = 3.0,P = 0.064)、晚期癌症分期(HR = 6.5,P = 0.077)和体表面积超过 1.71 m²(HR = 3.4,P = 0.029)增加了端口系统阻塞的风险。

结论

我们的研究表明,在终末期患者中,完全植入式端口系统的并发症风险更高。应仔细进行进一步调查,以比较各种中心静脉通路装置在晚期癌症患者中的结局,并制定针对导管故障的预防策略。

相似文献

1
Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.晚期癌症患者使用完全植入式静脉输液港系统的并发症风险更高——单中心回顾性分析。
Palliat Med. 2013 Feb;27(2):185-91. doi: 10.1177/0269216311428777. Epub 2011 Nov 29.
2
The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.完全植入式中心静脉通路端口的晚期并发症:一项意大利多中心前瞻性观察研究结果。
Eur J Oncol Nurs. 2011 Dec;15(5):377-81. doi: 10.1016/j.ejon.2010.11.007. Epub 2010 Dec 16.
3
Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.完全植入式静脉通路端口:81例患者长期并发症的回顾性研究
Indian J Cancer. 2012 Jan-Mar;49(1):114-8. doi: 10.4103/0019-509X.98934.
4
Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.癌症患者中心静脉导管和完全植入式输液港的血栓形成和感染风险。
Thromb Res. 2010 Apr;125(4):318-21. doi: 10.1016/j.thromres.2009.06.008. Epub 2009 Jul 28.
5
Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.完全植入式静脉输液港系统及其并发症的危险因素:癌症中心的一项为期一年的前瞻性研究。
Eur J Surg Oncol. 2011 Oct;37(10):913-8. doi: 10.1016/j.ejso.2011.06.016. Epub 2011 Aug 9.
6
Morbidity after insertion of totally implantable venous access ports in oncological patients: results of a retrospective clinical study.肿瘤患者植入全植入式静脉通路端口后的发病率:一项回顾性临床研究结果
Am Surg. 2014 Feb;80(2):204-7.
7
Association between risk of bloodstream infection and duration of use of totally implantable access ports and central lines: a 24-month study.完全植入式输液港和中心静脉导管使用时间与血流感染风险的关系:一项 24 个月的研究。
Am J Infect Control. 2011 Sep;39(7):e39-43. doi: 10.1016/j.ajic.2010.11.013. Epub 2011 Jun 11.
8
Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients.完全植入式静脉通路端口系统的并发症相关移除:放置与首次使用之间的间隔以及化疗方案诱导中性粒细胞减少的可能性是否会影响其发生率?一项针对4045例患者的四年前瞻性研究。
Eur J Surg Oncol. 2017 Apr;43(4):689-695. doi: 10.1016/j.ejso.2016.10.020. Epub 2016 Nov 5.
9
Complications associated with an implantable vascular access device.与植入式血管通路装置相关的并发症。
J Pediatr Surg. 2006 Sep;41(9):1582-7. doi: 10.1016/j.jpedsurg.2006.05.022.
10
Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.妇科恶性肿瘤化疗患者使用低剖面皮下植入式静脉通路装置的机械故障发生率。
Gynecol Oncol. 2011 Oct;123(1):54-7. doi: 10.1016/j.ygyno.2011.06.012. Epub 2011 Jul 13.

引用本文的文献

1
Analysis of the reasons for removal of vascular ports in patients treated in chemotherapy and gynecological oncology departments - preliminary investigations.化疗及妇科肿瘤科室患者血管通路拔除原因分析——初步调查
Prz Menopauzalny. 2025 Jun;24(2):102-112. doi: 10.5114/pm.2025.152126. Epub 2025 Jun 16.
2
Predictive model for totally implanted venous access ports‑related long‑term complications in patients with lung cancer.肺癌患者完全植入式静脉输液港相关长期并发症的预测模型
Oncol Lett. 2024 May 15;28(1):326. doi: 10.3892/ol.2024.14459. eCollection 2024 Jul.
3
Complications of Central Venous Access Devices Used in Palliative Care Settings for Terminally Ill Cancer Patients: A Systematic Review and Meta-Analysis.
用于晚期癌症患者姑息治疗的中心静脉通路装置的并发症:一项系统评价和荟萃分析
Cancers (Basel). 2023 Sep 25;15(19):4712. doi: 10.3390/cancers15194712.
4
Outcomes following port-a-catheter placement in the Medicare population.医疗保险人群中植入输液港后的治疗结果。
Surg Open Sci. 2020 Nov 11;3:39-43. doi: 10.1016/j.sopen.2020.10.002. eCollection 2021 Jan.
5
Role of Lock Therapy for Long-Term Catheter-Related Infections by Multidrug-Resistant Bacteria.多药耐药菌所致长期导管相关性感染的封管治疗作用。
Antimicrob Agents Chemother. 2018 Aug 27;62(9). doi: 10.1128/AAC.00569-18. Print 2018 Sep.
6
A Study of Use of "PORT" Catheter in Patients with Cancer: A Single-Center Experience.癌症患者“PORT”导管使用情况的研究:单中心经验
Clin Med Insights Oncol. 2017 Feb 23;11:1179554917691031. doi: 10.1177/1179554917691031. eCollection 2017.
7
Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines.肝脏超声检查评分可预测血清转氨酶正常的局部晚期头颈癌患者在多西他赛诱导化疗中与治疗相关的严重中性粒细胞减少和中性粒细胞减少性发热。
Support Care Cancer. 2016 Nov;24(11):4697-703. doi: 10.1007/s00520-016-3318-8. Epub 2016 Jun 21.
8
Totally implantable venous access port systems and associated complications: A single-institution retrospective analysis of 2,996 breast cancer patients.完全植入式静脉通路端口系统及相关并发症:对2996例乳腺癌患者的单机构回顾性分析。
Mol Clin Oncol. 2016 Mar;4(3):456-460. doi: 10.3892/mco.2016.726. Epub 2016 Jan 7.
9
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.靶向抗癌治疗时代中心静脉导管局部并发症发生率增加:一项为期两年的回顾性分析。
Support Care Cancer. 2015 May;23(5):1295-302. doi: 10.1007/s00520-014-2466-y. Epub 2014 Oct 19.
10
A comparison of outcomes and complications of totally implantable access port through the internal jugular vein versus the subclavian vein.经颈内静脉与锁骨下静脉置入全植入式输液港的结局与并发症比较。
Int Surg. 2014 Mar-Apr;99(2):182-8. doi: 10.9738/INTSURG-D-13-00185.1.